JPH0153280B2 - - Google Patents

Info

Publication number
JPH0153280B2
JPH0153280B2 JP55149497A JP14949780A JPH0153280B2 JP H0153280 B2 JPH0153280 B2 JP H0153280B2 JP 55149497 A JP55149497 A JP 55149497A JP 14949780 A JP14949780 A JP 14949780A JP H0153280 B2 JPH0153280 B2 JP H0153280B2
Authority
JP
Japan
Prior art keywords
methyl
group
androstan
alkyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55149497A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5673097A (en
Inventor
Uiihieruto Ruudorufu
Bitsutoraa Deiitaa
Shuroizenaa Anerooze
Arupuringu Manfureeto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS5673097A publication Critical patent/JPS5673097A/ja
Publication of JPH0153280B2 publication Critical patent/JPH0153280B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0044—Alkenyl derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
JP14949780A 1979-10-26 1980-10-27 17 alphaaalkylsteroid* its manufacture and blend containing it and having antiandrogenic activity Granted JPS5673097A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792943776 DE2943776A1 (de) 1979-10-26 1979-10-26 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
JPS5673097A JPS5673097A (en) 1981-06-17
JPH0153280B2 true JPH0153280B2 (OSRAM) 1989-11-13

Family

ID=6084722

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14949780A Granted JPS5673097A (en) 1979-10-26 1980-10-27 17 alphaaalkylsteroid* its manufacture and blend containing it and having antiandrogenic activity

Country Status (23)

Country Link
US (4) US4344941A (OSRAM)
EP (1) EP0027961B1 (OSRAM)
JP (1) JPS5673097A (OSRAM)
AT (1) ATE2221T1 (OSRAM)
AU (1) AU532515B2 (OSRAM)
CA (1) CA1160216A (OSRAM)
CS (1) CS228507B2 (OSRAM)
DD (1) DD153694A5 (OSRAM)
DE (2) DE2943776A1 (OSRAM)
DK (1) DK163002C (OSRAM)
EG (1) EG14998A (OSRAM)
ES (1) ES8106539A1 (OSRAM)
FI (1) FI69850C (OSRAM)
GR (1) GR71212B (OSRAM)
HU (1) HU183237B (OSRAM)
IE (1) IE52686B1 (OSRAM)
IL (1) IL61332A (OSRAM)
NO (1) NO154231C (OSRAM)
PL (1) PL125169B1 (OSRAM)
PT (1) PT71842B (OSRAM)
SU (1) SU973025A3 (OSRAM)
YU (1) YU256680A (OSRAM)
ZA (1) ZA806565B (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2943776A1 (de) * 1979-10-26 1981-05-14 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
DE3115996A1 (de) * 1981-04-13 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen 17(alpha)-alkyl-17(beta)-hydroxy-1(alpha)- methyl-4-androsten-3-one-.verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
US6150405A (en) * 1985-07-18 2000-11-21 Proctor; Peter H. Hair loss treatment with ascorbates
US5714510A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical proxyl composition and method
US5728714A (en) * 1985-07-18 1998-03-17 Proctor; Peter H. Method for treating hair loss using tempo
US5470876A (en) * 1985-07-18 1995-11-28 Proctor; Peter H. Topical sod for treating hair loss
US5714482A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical spin labels and method
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
US5716947A (en) * 1985-07-18 1998-02-10 Proctor; Peter H. Topical doxyl composition and method
US5472687A (en) * 1985-07-18 1995-12-05 Proctor; Peter H. Topical pyridine N-oxides
US5723502A (en) * 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
DE3824247A1 (de) * 1988-07-13 1990-01-18 Schering Ag Neue androstan-derivate
ES2093722T3 (es) * 1991-01-24 1997-01-01 Rheinische Braunkohlenw Ag Procedimiento para el tratamiento de desechos.
US5328686A (en) * 1991-10-30 1994-07-12 Douglas Shander Treatment of acne or of pseudofolliculitis barbae
ES2173874T3 (es) * 1991-11-05 2002-11-01 Gillette Co Alteracion de la velocidad y caracter del crecimiento del pelo.
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US5648394A (en) * 1993-05-27 1997-07-15 Boxall; Brian Alfred Topical composition for inhibiting hair growth
US6414017B2 (en) 1993-05-28 2002-07-02 The Gillette Company Inhibition of hair growth
US6248751B1 (en) 1993-05-28 2001-06-19 Gurpreet S. Ahluwalia Inhibition of hair growth
EP0738275B9 (en) * 1994-01-06 2001-03-21 Sri International Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
US5474763A (en) * 1994-03-11 1995-12-12 Shander; Douglas Reduction of hair growth
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
US5455234A (en) * 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth
ES2175084T3 (es) * 1995-02-28 2002-11-16 Gillette Co Uso de supresores de angiogenesis para inhibir el crecimiento del pelo.
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
US5728736A (en) * 1995-11-29 1998-03-17 Shander; Douglas Reduction of hair growth
US5652273A (en) * 1995-11-30 1997-07-29 Henry; James Reduction of hair growth
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6294188B1 (en) 1998-07-09 2001-09-25 Aviana Biopharm Inc. Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
US20070129282A1 (en) * 1998-11-24 2007-06-07 Ahlem Clarence N Pharmaceutical treatments and compositions
CA2670236C (en) * 1999-09-30 2012-06-05 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
US7285109B2 (en) * 2003-02-13 2007-10-23 Boston Scientific Scimed, Inc. Device and method for collapsing an angioplasty balloon
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1382468A (fr) * 1964-01-28 1964-12-18 Spofa Vereinigte Pharma Werke Procédé de préparation des composés de 3-céto-androstane 1-méthyle-substitués, et produits conformes à ceux obtenus par le présent procédé ou procédé similaire
US3391168A (en) * 1965-08-23 1968-07-02 Searle & Co 1, 17-dimethyl-5-androstane-3beta, 17beta-diol and esters thereof
US3705180A (en) * 1971-09-02 1972-12-05 Paul D Klimstra 17-oxygenate-2-alpha-methyl-2-methylen-5 alpha-androstan-3-ones and intermediates
US4039669A (en) * 1975-08-01 1977-08-02 Sterling Drug Inc. Composition for topical application and use thereof
DE2943776A1 (de) * 1979-10-26 1981-05-14 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
US4456600A (en) 1984-06-26
GR71212B (OSRAM) 1983-04-11
FI69850C (fi) 1986-05-26
DK434380A (da) 1981-04-27
ES495740A0 (es) 1981-06-16
EG14998A (en) 1985-06-30
HU183237B (en) 1984-04-28
IE802202L (en) 1981-04-26
US4344941A (en) 1982-08-17
DD153694A5 (de) 1982-01-27
IL61332A (en) 1985-05-31
ATE2221T1 (de) 1983-01-15
NO154231B (no) 1986-05-05
EP0027961A1 (de) 1981-05-06
IL61332A0 (en) 1980-12-31
FI69850B (fi) 1985-12-31
NO803172L (no) 1981-04-27
EP0027961B1 (de) 1983-01-12
PL227468A1 (OSRAM) 1981-07-10
PT71842B (de) 1981-07-09
AU532515B2 (en) 1983-10-06
YU256680A (en) 1983-02-28
CS228507B2 (en) 1984-05-14
US4558041A (en) 1985-12-10
PL125169B1 (en) 1983-04-30
NO154231C (no) 1986-08-13
CA1160216A (en) 1984-01-10
DE2943776A1 (de) 1981-05-14
JPS5673097A (en) 1981-06-17
FI803342L (fi) 1981-04-27
PT71842A (de) 1980-10-01
SU973025A3 (ru) 1982-11-07
IE52686B1 (en) 1988-01-20
DK163002B (da) 1992-01-06
DK163002C (da) 1992-06-01
DE3061638D1 (en) 1983-02-17
AU6363780A (en) 1981-04-30
US4892867A (en) 1990-01-09
ZA806565B (en) 1981-10-28
ES8106539A1 (es) 1981-06-16

Similar Documents

Publication Publication Date Title
JPH0153280B2 (OSRAM)
EP2667876A2 (en) Methods and compounds for preparing 3alpha-oxygen substituted steroids
EP0349481A1 (de) 13-Alkyl-11Beta-phenylgonane
JP3328377B2 (ja) １１−ケトステロイド誘導体の新製造法
HU208437B (en) Process for producing 9-alpha-hydroxy- -17-methylene-steroides for synthetizing corticosteroides
JPS6254119B2 (OSRAM)
US4457925A (en) Androstane derivatives, process for their production, and pharmaceutical preparations containing them
EP1242444B1 (en) Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
HU186074B (en) Process for producing mono- and bis-quaternary ammonium-derivatives of 2-beta,16-beta-diamino-5-alpha-androstanes
JPS6355488B2 (OSRAM)
JPS636559B2 (OSRAM)
EP1339733B1 (de) Verfahren zur herstellung von 4-(17alpha-methyl-substituierten)3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e oder 1z)-oximen
DE2749105C2 (de) Verfahren zur Herstellung von Δ↑1↑↑5↑-17α-Chloräthinyl- und Propinylsteroiden der Östranreihe
EP0655071B1 (de) VERFAHREN ZUR HERSTELLUNG VON 1-METHYL-3-KETO-$g(D)?1,4 -STEROIDEN
AP157A (en) Novel steroid derivatives.
JPS641480B2 (OSRAM)
DE2001262A1 (de) 19-Homosteroide
DE2943778A1 (de) 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
DE2223343A1 (de) In 12-Stellung substituierte Steroide
DE3023568A1 (de) 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
JPS6165898A (ja) １１−アンドロステン誘導体および抗アンドロジエン剤
DE2211817A1 (de) Verfahren zur Herstellung von Dinorcholestan Derivaten
DE1493114B2 (OSRAM)